This narrative review examines the advantages and disadvantages of direct-to-consumer teledermatology for the treatment of male androgenetic alopecia, finding that this treatment modality improves access to care, ensures high adherence rates, and enhances patient satisfaction, while raising concerns about increased drug costs.
Keywords: androgenetic alopecia; direct-to-consumer; finasteride; male pattern hair loss; teledermatology; telemedicine.
© Finn Abeck, Inga Hansen-Abeck, Julian Kött, Edward Garrahy, Stefan W Schneider, Johannes von Büren. Originally published in JMIR Dermatology (http://derma.jmir.org).